181 related articles for article (PubMed ID: 26990255)
1. Correlation Between Appropriate Use Criteria and the Frequency of Subclinical Spread or Reconstruction With a Flap or Graft for Melanomas Treated With Mohs Surgery With Melanoma Antigen Recognized by T Cells 1 Immunostaining.
Etzkorn JR; Sobanko JF; Shin TM; Elenitsas R; Chu EY; Gelfand JM; Margolis DJ; Newman JG; Goldbach H; Miller CJ
Dermatol Surg; 2016 Apr; 42(4):471-6. PubMed ID: 26990255
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathologic factors associated with subclinical spread of invasive melanoma.
Shin TM; Shaikh WR; Etzkorn JR; Sobanko JF; Margolis DJ; Gelfand JM; Chu EY; Elenitsas R; Miller CJ
J Am Acad Dermatol; 2017 Apr; 76(4):714-721. PubMed ID: 28139264
[TBL] [Abstract][Full Text] [Related]
3. Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation.
Etzkorn JR; Jew OS; Shin TM; Sobanko JF; Neal DE; Miller CJ
J Am Acad Dermatol; 2018 Dec; 79(6):1109-1116.e1. PubMed ID: 30003986
[TBL] [Abstract][Full Text] [Related]
4. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
5. Clinical factors associated with subclinical spread of in situ melanoma.
Shin TM; Etzkorn JR; Sobanko JF; Margolis DJ; Gelfand JM; Chu EY; Elenitsas R; Shaikh WR; Miller CJ
J Am Acad Dermatol; 2017 Apr; 76(4):707-713. PubMed ID: 28073583
[TBL] [Abstract][Full Text] [Related]
6. Melanomas of the head and neck have high-local recurrence risk features and require tissue-rearranging reconstruction more commonly than basal cell carcinoma and squamous cell carcinoma: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors.
Fix W; Etzkorn JR; Shin TM; Howe N; Bhatt M; Sobanko JF; Miller CJ
J Am Acad Dermatol; 2021 Aug; 85(2):409-418. PubMed ID: 30458206
[TBL] [Abstract][Full Text] [Related]
7. Mohs micrographic surgery for melanoma: A prospective multicenter study.
Ellison PM; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
[TBL] [Abstract][Full Text] [Related]
8. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
[TBL] [Abstract][Full Text] [Related]
9. Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery.
MacArthur KM; Baumann BC; Sobanko JF; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; McMurray SL; Krausz A; Newman JG; Rajasekaran K; Cannady SB; Brody RM; Karakousis GC; Miura JT; Cohen JV; Amaravadi RK; Mitchell TC; Schuchter LM; Miller CJ
Cancer; 2021 Oct; 127(19):3591-3598. PubMed ID: 34292585
[TBL] [Abstract][Full Text] [Related]
10. The rule of 10s versus the rule of 2s: High complication rates after conventional excision with postoperative margin assessment of specialty site versus trunk and proximal extremity melanomas.
Rzepecki AK; Hwang CD; Etzkorn JR; Shin TM; Sobanko JF; Howe NM; Miller CJ
J Am Acad Dermatol; 2021 Aug; 85(2):442-452. PubMed ID: 30447316
[TBL] [Abstract][Full Text] [Related]
11. The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Siscos SM; Neill BC; Seger EW; Hooton TA; Hocker TLH
Dermatol Surg; 2020 Oct; 46(10):1267-1271. PubMed ID: 32740213
[TBL] [Abstract][Full Text] [Related]
12. Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas.
Shin TM; Nugent S; Aizman L; Weiner DM; O'Malley V; Sobanko JF; Etzkorn JR; Chu EY; Elenitsas R; Giordano CN; Higgins Ii HW; Miller CJ
J Am Acad Dermatol; 2021 Jan; 84(1):196-198. PubMed ID: 32339704
[No Abstract] [Full Text] [Related]
13. Slow Mohs Micrographic Surgery for Acral Melanoma Treatment in Korean Patients.
Seo J; Oh Y; Kim SK; Roh MR; Chung KY
Dermatol Surg; 2021 Feb; 47(2):e42-e46. PubMed ID: 33481431
[TBL] [Abstract][Full Text] [Related]
14. Digit-Sparing Mohs Surgery for Melanoma.
Terushkin V; Brodland DG; Sharon DJ; Zitelli JA
Dermatol Surg; 2016 Jan; 42(1):83-93. PubMed ID: 26655701
[TBL] [Abstract][Full Text] [Related]
15. Benefit of Mohs Micrographic Surgery Over Wide Local Excision for Melanoma of the Head and Neck: A Rational Approach to Treatment.
Demer AM; Vance KK; Cheraghi N; Reich HC; Lee PK
Dermatol Surg; 2019 Mar; 45(3):381-389. PubMed ID: 30550523
[TBL] [Abstract][Full Text] [Related]
16. Outcomes for Invasive Melanomas Treated With Mohs Micrographic Surgery: A Retrospective Cohort Study.
Degesys CA; Powell HB; Hsia LB; Merritt BG
Dermatol Surg; 2019 Feb; 45(2):223-228. PubMed ID: 30199430
[TBL] [Abstract][Full Text] [Related]
17. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review of the Role of Mohs Micrographic Surgery in the Management of Early-Stage Melanoma of the Head and Neck.
Theunissen CCW; Lee MH; Murad FG; Waldman AH
Dermatol Surg; 2021 Sep; 47(9):1185-1189. PubMed ID: 34148999
[TBL] [Abstract][Full Text] [Related]
19. Frequency of and risk factors for tumor upstaging after wide local excision of primary cutaneous melanoma.
Etzkorn JR; Sharkey JM; Grunyk JW; Shin TM; Sobanko JF; Miller CJ
J Am Acad Dermatol; 2017 Aug; 77(2):341-348. PubMed ID: 28601390
[TBL] [Abstract][Full Text] [Related]
20. Surgical margins for excision of primary cutaneous melanoma.
Zitelli JA; Brown CD; Hanusa BH
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):422-9. PubMed ID: 9308558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]